Aviva Goral

Dr. Aviva Goral


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ABAsaf Biber
Asaf Biber
IAIzeldeen Abuelaish
Izeldeen Abuelaish
GRGalia Rahav
Galia Rahav
MRMeir Raz
Meir Raz
LCLiran Cohen
Liran Cohen
FGfor the PICR Study Group
for the PICR Study Group
Epidemiological data on community acquired methicillin-resistant-Staphylococcus aureus (CA-MRSA) carriage and infection in the Middle-East region is scarce with only few reports in the Israeli and Palestinian populations. As part of a Palestinian-Israeli collaborative research, we have conducted a cross-sectional survey of nasal S. aureus carriage in healthy children and their parents throughout the Gaza strip. Isolates were characterized for antibiotic susceptibility, mec gene presence, PFGE, spa type, SCCmec-type, presence of PVL genes and multi-locus-sequence-type (MLST). S. aureus was carried by 28.4% of the 379 screened children-parents pairs. MRSA was detected in 45% of S. aureus isolates, that is, in 12% of the study population. A single ST22-MRSA-IVa, spa t223, PVL-gene negative strain was detected in 64% of MRSA isolates. This strain is typically susceptible to all non-β-lactam antibiotics tested. The only predictor for MRSA carriage in children was having an MRSA carrier-parent (OR = 25.5, P = 0.0004). Carriage of the Gaza strain was not associated with prior hospitalization. The Gaza strain was closely related genetically to a local MSSA spa t223 strain and less so to EMRSA15, one of the pandemic hospital-acquired-MRSA clones, scarcely reported in the community. The rapid spread in the community may be due to population determinants or due to yet unknown advantageous features of this particular strain.

27 May 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AGAviva Goral
Aviva Goral
PFPaula Feder-Bubis
Paula Feder-Bubis
MLMooli Lahad
Mooli Lahad
SGSandro Galea
Sandro Galea
Norm O'RourkeNorm O'Rourke
Norm O'Rourke
Limor Aharonson-DanielLimor Aharonson-Daniel
Limor Aharonson-Daniel
Background: Current diagnostic criteria for posttraumatic stress disorder (PTSD) do not include symptoms resulting from exposure to continuous or ongoing traumatic stress. Thus existing assessment tools do not fully capture stress symptoms associated with exposure to threats that extend over months or years. To address this void, we enumerated the symptoms associate with ongoing exposure to stress including those that are distinct from existing PTSD diagnostic criteria. Objectives: To develop the Continuous Traumatic Stress Response Scale (CTSR) and assess its psychometric properties. Method: We sampled 313 adults exposed and unexposed to ongoing security threat between December 2016 and February 2017. Respondents lived in communities bordering the Gaza Strip in southern Israel where they are exposed to frequent rocket attacks, requiring they locate and find shelter in 30 seconds or less. We assessed the concurrent validity of CTSR relative to the Posttraumatic Diagnostic Scale (PDS). Results: On the basis of exploratory factor analysis (EFA), we retained 11 of 25 items measuring three distinct factors: exhaustion/detachment, rage/betrayal, and fear/helplessness. We found moderate concurrence between the scales; that is, the CTSR appears to measure a construct related to, but distinct from PTSD. This conclusion is supported by confirmatory factor analysis (CFA) indicating that each factor significantly contributes to measurement of a higher-order, continuous traumatic stress latent construct. Conclusions: These results support the psychometric properties of CTSR. Future research is required to confirm these findings in other countries and cultures and among individuals exposed to other forms of continuous traumatic stress.

1 April 2012 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
ELEyal Leshem
Eyal Leshem
AMAyala Maayan-Metzger
Ayala Maayan-Metzger
GRGalia Rahav
Galia Rahav
MDMordechai Dolitzki
Mordechai Dolitzki
JKJacob Kuint
Jacob Kuint
GRGili Regev-Yochay
Gili Regev-Yochay
Background: The study objective was to define the risk factors and the route of Staphylococcus aureus transmission between mother and newborn. Methods: Women at late pregnancy were screened for nasal and vaginal S. aureus colonization. Newborns were screened for nasal, auricular, umbilical, and rectal colonization at birth and before discharge. Carrier mothers and their newborns were rescreened at 1 month. Pulse-field gel electrophoresis was used to assess strain genetic relatedness. Results: Of the 208 women screened, 34% were colonized with S. aureus. Overall, by 72–100 hours after birth, the cumulative incidence of S. aureus acquisition was 42.6/100 newborns of carrier mothers versus 7.4/100 newborns of noncarrier mothers (adjusted risk ratio = 5.7; 95% confidence interval [CI], 2.3–13.9). The risk to acquire a maternal strain was significantly higher than nonmaternal strain (adjusted risk ratio = 1.5; 95% CI, 1.3–1.9); Newborns to carrier mothers were also at a risk to acquire nonmaternal S. aureus strains compared with newborns to noncarrier mothers (adjusted risk ratio = 2.9; 95% CI, 1.6–5.4). The cumulative incidence of S. aureus acquisition was similar among newborns delivered by cesarean versus vaginal delivery (24.5 vs. 23.0/100 cases). At 1-month follow-up, the cumulative incidence of S. aureus acquisition reached 69.7/100 newborns of carrier mothers. Genetically identical strains were isolated in 32/40 (80%) mother-newborn pairs, among these, the source of the newborn strain was a maternal nasal strain in 29/32 (90%). Conclusions: Newborns of carrier mothers are at risk to acquire S. aureus colonization. Most newborns of carrier mothers are colonized within the first month of life. Horizontal transmission from the mother is probably the major source for S. aureus carriage in newborns.

1 December 2017 in Psychiatry Research
Verified
Journal Article
Closed access
AGAviva Goral
Aviva Goral
MLMooli Daniel LAHAD
Mooli Daniel LAHAD
Limor Aharonson-DanielLimor Aharonson-Daniel
Limor Aharonson-Daniel

1 February 2015 in Vaccine
Verified
Journal Article
Closed access
MDMuhannad Daana
Muhannad Daana
GRGalia Rahav
Galia Rahav
AHAyob Hamdan
Ayob Hamdan
ATAmin Thalji
Amin Thalji
FJFuad Jaar
Fuad Jaar
GRGili Regev-Yochay
Gili Regev-Yochay

1 January 2012 in General Hospital Psychiatry
Verified
Journal Article
Closed access
AGAviva Goral
Aviva Goral
JLJoshua D. Lipsitz
Joshua D. Lipsitz
KMKhitam Muhsen
Khitam Muhsen
RGRaz Gross
Raz Gross